Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

Maria Thompson

Maria Thompson, PhD has a background in molecular genetics and over 16 years of experience in pharmaceutical and diagnostics research and development. She has held a variety of roles including Head of Genome Wide Screening for Type 2 diabetes, Six Sigma Black Belt, and VP of Scientific Affairs. Dr. Thompson is a Principal Consultant at APEX Think, a private consulting company providing scientific and technical advisory services to clients across the life science industry. Dr. Thompson holds a BSc in Genetics and a PhD in Molecular and Cellular Biochemistry from the Royal London School of Medicine, UK.
Showing 1-10 of 110 posts
Jun 30, 2014

Over the course of this series so far we’ve looked at the role of the microbiome in two of the three major therapeutic areas targeted by drug...

Jun 18, 2014

Outsourcing has proven to reduce costs while dramatically improving productivity of the drug discovery process. Primary benefits to outsourcing...

Jun 16, 2014

Having introduced the age of the microbiome in drug discovery and the microbiome in metabolic disease we now turn to the influence of the...

Apr 30, 2014

In the Age of the Microbiome blog post which initiated this series we introduced the spectacular potential that the microbiome offers for drug...

Apr 18, 2014

Outsourcing drug discovery and development has become the key to making the entire drug research process more efficient. Over the past few years...

Apr 9, 2014

Over the course of the last century we’ve had the age of antibiotics, the genetic revolution, transplantation and immunotherapy, each of which...

Feb 24, 2014

Published in The Coast News last week, was a great article about how Bio, Tech and Beyond, the darling incubator lab of San Diego, is providing...

Feb 11, 2014

Three outstanding examples for fragment-based drug discovery A good example for the reliability of the fragment-based screening method is the...

Feb 6, 2014

Directed evolution is emerging as a powerful new tool to design proteins with new and interesting properties that may not have evolved naturally...

Jan 30, 2014

The selection and accumulation of desirable mutations – also known as natural selection – has shaped the living world. The proteins resulting from...